[Influenza-like illness. Therapeutic experience in family medicine]

Gerardo Muñoz-Cortés1, Guadalupe Ulises García-Zavala, María Elena Estrada-Andrade

  • 1Unidad de Medicina, Instituto Mexicano del Seguro Social, Salvatierra, Guanajuato, Mexico. gerardo_zirahuen@hotmail.com

Abstract

Insights

Early diagnosis and treatment of Influenza-Like Illness (ILI) in a family medicine unit protocol led to favorable patient outcomes, with all patients recovering without complications. This highlights the importance of timely intervention for influenza.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Family Medicine

Context:

  • Influenza is a contagious respiratory illness requiring prompt treatment to prevent complications like pneumonia.
  • Surveillance in Mexico relies on identifying Influenza-Like Illness (ILI).
  • Antiviral treatment for influenza is most effective when initiated within 48 hours of symptom onset.

Purpose:

  • To describe the experience of treating Influenza-Like Illness (ILI) within a family medicine unit.
  • To evaluate the effectiveness of a protocol for ILI management.

Summary:

  • A descriptive study analyzed patients presenting with ILI symptoms (fever, cough, headache).
  • Out of 537 patients with upper airway infections, 1.3% met ILI criteria; 85.7% were male, with a mean age of 18 years.
  • All patients received antiviral treatment (oseltamivir/zanamivir) within a mean of 19.14 hours; 14.3% developed pneumonia, but all recovered fully.

Impact:

  • Implementing a protocol for influenza management in family medicine facilitates early diagnosis and treatment.
  • Timely intervention positively impacts patient recovery and prevents severe complications.
  • This study underscores the value of standardized protocols in managing infectious respiratory diseases in primary care settings.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccinations01:51

Vaccinations

Overview
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...